Works matching IS 00070920 AND DT 2021 AND VI 124 AND IP 10

Results: 21

Retraction Note to: Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells.

Published in:

2021

By:

Zhang, X.;
Ling, M.-T.;
Feng, H.;
Wong, Y. C.;
Tsao, S. W.;
Wang, X.

Publication type:

corrected article

Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis.

Published in:

2021

By:

Sparber-Sauer, Monika;
Orbach, Daniel;
Navid, Fariba;
Hettmer, Simone;
Skapek, Stephen;
Corradini, Nadège;
Casanova, Michela;
Weiss, Aaron;
Schwab, Matthias;
Ferrari, Andrea

Publication type:

journal article

Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer.

Published in:

2021

By:

Lepage, Chloe Camille;
Palmer, Michaela Cora Lynn;
Farrell, Ally Catherina;
Neudorf, Nicole Marie;
Lichtensztejn, Zelda;
Nachtigal, Mark William;
McManus, Kirk James

Publication type:

journal article

No need for H2-antagonists in premedication regimens for paclitaxel infusions: less is more.

Published in:

2021

By:

Gelderblom, Hans;
Zwaveling, Juliette

Publication type:

Editorial

RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance.

Published in:

2021

By:

Paramasivam, Arumugam;
Priyadharsini, Jayaseelan Vijayashree

Publication type:

journal article

The added value of H2 antagonists in premedication regimens during paclitaxel treatment.

Published in:

2021

By:

Cox, Juul M.;
van Doorn, Leni;
Malmberg, Ruben;
Oomen-de Hoop, Esther;
Bosch, Tessa M.;
van den Bemt, Patricia M. L. A.;
Boere, Ingrid A.;
Jager, Agnes;
Mathijssen, Ron H. J.;
van Leeuwen, Roelof W. F.

Publication type:

journal article

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: a propensity-matched survival analysis.

Published in:

2021

By:

van Breeschoten, Jesper;
Wouters, Michel W. J. M.;
Hilarius, Doranne L.;
Haanen, John B.;
Blank, Christian U.;
Aarts, Maureen J. B.;
van den Berkmortel, Franchette W. P. J.;
de Groot, Jan-Willem B.;
Hospers, Geke A. P.;
Kapiteijn, Ellen;
Piersma, Djura;
van Rijn, Roos S.;
Suijkerbuijk, Karijn P. M.;
Blokx, Willeke A. M.;
ten Tije, Bert-Jan J.;
van der Veldt, Astrid A. M.;
Vreugdenhil, Art;
Boers-Sonderen, Marye J.;
van den Eertwegh, Alfonsus J. M.

Publication type:

corrected article

Correction: Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity.

Published in:

2021

By:

Gehring, Kalle;
Miki, Hiroaki

Publication type:

corrected article

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.

Published in:

2021

By:

Ye, Weiyu;
Olsson-Brown, Anna;
Watson, Robert A.;
Cheung, Vincent T. F.;
Morgan, Robert D.;
Nassiri, Isar;
Cooper, Rosalin;
Taylor, Chelsea A.;
Akbani, Umair;
Brain, Oliver;
Matin, Rubeta N.;
Coupe, Nicholas;
Middleton, Mark R.;
Coles, Mark;
Sacco, Joseph J.;
Payne, Miranda J.;
Fairfax, Benjamin P.

Publication type:

journal article

Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer.

Published in:

2021

By:

Rakaee, Mehrdad;
Kilvaer, Thomas K.;
Jamaly, Simin;
Berg, Thomas;
Paulsen, Erna-Elise;
Berglund, Marte;
Richardsen, Elin;
Andersen, Sigve;
Al-Saad, Samer;
Poehl, Mette;
Pezzella, Francesco;
Kwiatkowski, David J.;
Bremnes, Roy M.;
Busund, Lill-Tove Rasmussen;
Donnem, Tom

Publication type:

journal article

A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.

Published in:

2021

By:

Halle, Mari K.;
Sødal, Marte;
Forsse, David;
Engerud, Hilde;
Woie, Kathrine;
Lura, Njål G.;
Wagner-Larsen, Kari S.;
Trovik, Jone;
Bertelsen, Bjørn I.;
Haldorsen, Ingfrid S.;
Ojesina, Akinyemi I.;
Krakstad, Camilla

Publication type:

journal article

Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort.

Published in:

2021

By:

Jobard, Elodie;
Dossus, Laure;
Baglietto, Laura;
Fornili, Marco;
Lécuyer, Lucie;
Mancini, Francesca Romana;
Gunter, Marc J.;
Trédan, Olivier;
Boutron-Ruault, Marie-Christine;
Elena-Herrmann, Bénédicte;
Severi, Gianluca;
Rothwell, Joseph A.

Publication type:

journal article

Pancreatic cancer cachexia: three dimensions of a complex syndrome.

Published in:

2021

By:

Kordes, Maximilian;
Larsson, Lars;
Engstrand, Lars;
Löhr, J.-Matthias

Publication type:

journal article

Retraction Note to: The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.

Published in:

2021

By:

Mandal, M.;
Kim, S.;
Younes, M. N.;
Jasser, S. A.;
El-Naggar, A. K.;
Mills, G. B.;
Myers, J. N.

Publication type:

corrected article

Correction to: The impact of COVID-19 on systemic anticancer treatment delivery in Scotland.

Published in:

2021

By:

Baxter, Mark A.;
Murphy, John;
Cameron, David;
Jordan, Judith;
Crearie, Christine;
Lilley, Christina;
Sadozye, Azmat;
Maclean, Mary;
Hall, Peter;
Phillips, Angela;
Greger, Alex;
Madeleine, Jude;
Petty, Russell D.

Publication type:

corrected article

Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer.

Published in:

2021

By:

Chen, Yunyun;
Maniakas, Anastasios;
Tan, Lin;
Cui, Meng;
Le, Xiangdong;
Niedzielski, Joshua S.;
Michel, Keith A.;
Harlan, Collin J.;
Lu, Wuhao;
Henderson, Ying C.;
Mohamed, Abdallah S. R.;
Lorenzi, Philip L.;
Putluri, Nagireddy;
Bankson, James A.;
Sandulache, Vlad C.;
Lai, Stephen Y.

Publication type:

journal article

Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis.

Published in:

2021

By:

Wang, Chenran;
Haas, Michael A.;
Yeo, Syn Kok;
Paul, Ritama;
Yang, Fuchun;
Vallabhapurapu, Subrahmanya;
Qi, Xiaoyang;
Plas, David R.;
Guan, Jun-Lin

Publication type:

journal article

Racial/ethnic differences in anthropometric and hormone-related factors and endometrial cancer risk: the Multiethnic Cohort Study.

Published in:

2021

By:

Sarink, Danja;
Wilkens, Lynne R.;
White, Kami K.;
Le Marchand, Loïc;
Wu, Anna H.;
Setiawan, V. Wendy;
Park, S. Lani;
Park, Song-Yi;
Killeen, Jeffrey L.;
Merritt, Melissa A.

Publication type:

journal article

Quantification of biomarker functionality predicts patient outcomes.

Published in:

2021

By:

Larijani, Banafshé;
Miles, James;
Ward, Stephen G.;
Parker, Peter J.

Publication type:

journal article

Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?

Published in:

2021

By:

Knight, William R. C.;
Baker, Cara R.;
Griffin, Nyree;
Wulaningsih, Wahyu;
Kelly, Mark;
Davies, Andrew R.;
Gossage, James A.;
on behalf of the Guy's and St Thomas' Oesophago-Gastric Research Group;
Hynes, O.;
Tham, G.;
Iezzi, C.;
Bott, R.;
Maisey, N.;
Gaya, A.;
Ngan, S.;
Qureshi, A.;
Green, M.;
Jacques, A.;
Goh, V.;
Deere, H.

Publication type:

journal article

Understanding the impact of immune-mediated selection on lung cancer evolution.

Published in:

2021

By:

Rosenthal, Rachel;
Swanton, Charles;
McGranahan, Nicholas

Publication type:

journal article

Works matching IS 00070920 AND DT 2021 AND VI 124 AND IP 10

Retraction Note to: Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells.

Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis.

Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer.

No need for H<sub>2</sub>-antagonists in premedication regimens for paclitaxel infusions: less is more.

RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance.

The added value of H<sub>2</sub> antagonists in premedication regimens during paclitaxel treatment.

Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.

Correction: Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity.

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.

Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer.

A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease.

Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: a case-control study nested within the French E3N cohort.

Pancreatic cancer cachexia: three dimensions of a complex syndrome.

Retraction Note to: The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells.

Correction to: The impact of COVID-19 on systemic anticancer treatment delivery in Scotland.

Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer.

Autophagy mediated lipid catabolism facilitates glioma progression to overcome bioenergetic crisis.

Racial/ethnic differences in anthropometric and hormone-related factors and endometrial cancer risk: the Multiethnic Cohort Study.

Quantification of biomarker functionality predicts patient outcomes.

Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?

Understanding the impact of immune-mediated selection on lung cancer evolution.